Cost-effectiveness of fondaparinux versus enoxaparin in non-ST-elevation acute coronary syndrome in Canada (OASIS-5)

BACKGROUND: Acute coronary syndrome (ACS) refers to a spectrum of life-threatening cardiac diseases usually due to coronary artery plaque rupture, subsequent thrombin generation plaque activation and thrombus formation. To date, no economic analyses have been published about the use of fondaparinux...

Descripción completa

Detalles Bibliográficos
Autores principales: Alfonso Ross Terres, Jorge, Lozano-Ortega, G., Kendall, R., Sculpher, M. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4696110/
https://www.ncbi.nlm.nih.gov/pubmed/26715178
http://dx.doi.org/10.1186/s12872-015-0175-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4696110/
https://www.ncbi.nlm.nih.gov/pubmed/26715178
http://dx.doi.org/10.1186/s12872-015-0175-1

Ejemplares similares